Head and Neck Carcinoma — Trials

Head and Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,921 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,013
Recruiting: 533
Ph III recruiting: 91
Growth YoY: +21.4%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 33.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (347)

clinicaltrialsPublishedShowing 251–257 of 257 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04813705	18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma	recruiting	Phase 2	93	Taizhou HospitalOTHER	1	Feb 21, 2023	clinicaltrials
NCT05652192	SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC	recruiting	Phase 2	37	Zhejiang Cancer HospitalOTHER	1	Dec 15, 2022	clinicaltrials
NCT05514275